Serosurvey on healthcare personnel caring for patients with Ebola virus disease and Lassa virus in the United States
Author(s) -
Colleen S. Kraft,
Aneesh K. Mehta,
Jay B. Varkey,
G. Marshall Lyon,
Sharon Vanairsdale,
Sonia Bell,
Eileen M. Burd,
Mary Elizabeth Sexton,
Leslie Anne Cassidy,
Patricia Olinger,
K Rengarajan,
Vanessa Raabe,
Emily Davis,
John Henderson,
Paula DesRoches,
Yongxian Xu,
Mark J. Mulligan,
Bruce S. Ribner
Publication year - 2020
Publication title -
infection control and hospital epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.243
H-Index - 138
eISSN - 1559-6834
pISSN - 0899-823X
DOI - 10.1017/ice.2019.349
Subject(s) - ebola virus , medicine , lassa virus , vp40 , virology , lassa fever , seroconversion , vaccination , asymptomatic , infection control , virus , immunology , intensive care medicine
Healthcare personnel (HCP) were recruited to provide serum samples, which were tested for antibodies against Ebola or Lassa virus to evaluate for asymptomatic seroconversion.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom